Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

MLTX – moonlake immunotherapeutics - class a ordinary shares (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MLTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/6
10:12 am
mltx
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low Report
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Report
11/3
08:03 am
mltx
MoonLake Immunotherapeutics (NASDAQ:MLTX) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $30.00 price target on the stock.
Low Report
MoonLake Immunotherapeutics (NASDAQ:MLTX) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $30.00 price target on the stock.
Report
11/3
06:10 am
mltx
MoonLake Immunotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
Low Report
MoonLake Immunotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
Report
11/3
06:10 am
mltx
MoonLake Immunotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
Low Report
MoonLake Immunotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
Report
10/29
03:53 pm
mltx
Rating for MLTX
Low Report
Rating for MLTX
Report
10/29
03:53 pm
mltx
Rating for MLTX
Low Report
Rating for MLTX
Report
10/29
10:09 am
mltx
MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating.
Low Report
MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating.
Report
10/29
07:20 am
mltx
MoonLake Immunotherapeutics downgraded to Sell from Neutral at Citi
Low Report
MoonLake Immunotherapeutics downgraded to Sell from Neutral at Citi
Report
10/2
08:07 am
mltx
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
Medium Report
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
Report
10/2
06:09 am
mltx
MoonLake Immunotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
Medium Report
MoonLake Immunotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
Report
10/2
06:09 am
mltx
MoonLake Immunotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
Medium Report
MoonLake Immunotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
Report
9/30
04:26 pm
mltx
MoonLake Immunotherapeutics downgraded to Neutral from Buy at Goldman Sachs
Low Report
MoonLake Immunotherapeutics downgraded to Neutral from Buy at Goldman Sachs
Report
9/30
04:26 pm
mltx
MoonLake Immunotherapeutics downgraded to Neutral from Buy at Goldman Sachs
Low Report
MoonLake Immunotherapeutics downgraded to Neutral from Buy at Goldman Sachs
Report
9/30
04:26 pm
mltx
MoonLake Immunotherapeutics downgraded to Neutral from Buy at Goldman Sachs
Low Report
MoonLake Immunotherapeutics downgraded to Neutral from Buy at Goldman Sachs
Report
9/30
10:23 am
mltx
Rating for MLTX
High Report
Rating for MLTX
Report
9/30
10:23 am
mltx
Rating for MLTX
High Report
Rating for MLTX
Report
9/30
09:25 am
mltx
MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded by analysts at Wolfe Research from an "outperform" rating to an "underperform" rating. They now have a $2.00 price target on the stock.
High Report
MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded by analysts at Wolfe Research from an "outperform" rating to an "underperform" rating. They now have a $2.00 price target on the stock.
Report
9/30
09:25 am
mltx
MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded by analysts at Wolfe Research from an "outperform" rating to an "underperform" rating. They now have a $2.00 price target on the stock.
High Report
MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded by analysts at Wolfe Research from an "outperform" rating to an "underperform" rating. They now have a $2.00 price target on the stock.
Report
9/30
08:47 am
mltx
Rating for MLTX
High Report
Rating for MLTX
Report
9/30
08:47 am
mltx
Rating for MLTX
High Report
Rating for MLTX
Report
9/30
07:47 am
mltx
Rating for MLTX
Medium Report
Rating for MLTX
Report
9/30
07:47 am
mltx
Rating for MLTX
Medium Report
Rating for MLTX
Report
9/30
07:03 am
mltx
MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating.
High Report
MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating.
Report
9/30
06:20 am
mltx
Rating for MLTX
High Report
Rating for MLTX
Report
9/30
06:20 am
mltx
Rating for MLTX
High Report
Rating for MLTX
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2025, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0